Clinical Trial Update: Evaluation of Biosynthetic Constructs to Replace Donor Corneas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating biosynthetic constructs to replace donor corneas for corneal disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Disease

Snippet

Sponsor: Region Östergötland | Conditions: Corneal Disease | Phase 1 | Status: WITHDRAWN